Loading...

ISPR ISPIRE TECHNOLOGY INC US FDA Inspections 8-K Filing

SPR

SPR

ISPIRE TECHNOLOGY INC

(ISPR)

2024 8-K

Show Summary

Summary

Market Expansion

Financial Statements

Management Change

Accountant Change

Financial Results

Share Repurchase Program

FDA Meeting Update

Q1 Earnings Report

Financial Results

Financial Restatement

Investor Presentation

Appointment of CFO and Seni...

Financial Results Press Rel...

Joint Venture Agreement

Investment Offering

Financial Results Press Rel...

Change in Accounting Firm

Resignation of Auditor

Financial Results Press Rel...

Establishment of Subsidiary

Presentation Update

Financial Results Press Rel...

Restatement of Financial St...

Investor Conference

Appointment of Michael Wang...

Private Placement

Financial Results Announcement

Public Offering

External Links:

Ispire Technology Inc. announced a positive pre-PMTA submission meeting with the U.S. FDA on November 18, 2024, indicating progress in their regulatory process.

AI Assistant

ISPIRE TECHNOLOGY INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.